Travere Therapeutics
TVTX
TVTX
146 hedge funds and large institutions have $1.03B invested in Travere Therapeutics in 2020 Q2 according to their latest regulatory filings, with 34 funds opening new positions, 53 increasing their positions, 40 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
3.44% more ownership
Funds ownership: 102.09% → 105.53% (+3.4%)
44% less call options, than puts
Call options by funds: $2.83M | Put options by funds: $5.1M
Holders
146
Holding in Top 10
1
Calls
$2.83M
Puts
$5.1M
Top Buyers
| 1 | +$56.2M | |
| 2 | +$21.4M | |
| 3 | +$15.9M | |
| 4 |
Invesco
Atlanta,
Georgia
|
+$12.2M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
+$12.1M |
Top Sellers
| 1 | -$33.8M | |
| 2 | -$5.44M | |
| 3 | -$3.34M | |
| 4 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
-$3.22M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$878K |